Blood measurement of carcinoembryonic antigen level for detecting recurrence of colorectal cancer

Blood measurement of carcinoembryonic antigen level for detecting recurrence of colorectal cancer

What is the trade-off between sensitivity and specificity at specific carcinoembryonic antigen (CEA) thresholds for detecting recurrent colorectal cancer?To detect colorectal cancer recurrence, the sensitivity of CEA ranges from 68% for a threshold of 10 µg/L to 82% for a threshold of 2.5 µg/L and t...

Bibliográfalaš dieđut
Váldodahkkit:	Nicholson, B, Shinkins, B, Mant, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	American Medical Association 2016

Geahča maid

Carcinoembryonic antigen monitoring to detect recurrence of colorectal cancer: how should we interpret the test results?
Dahkki: Shinkins, B, et al.
Almmustuhtton: (2014)

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial
Dahkki: Shinkins, B, et al.
Almmustuhtton: (2018)

Blood CEA levels for detecting recurrent colorectal cancer: A Diagnostic Test Accuracy Review.
Dahkki: Nicholson, B, et al.
Almmustuhtton: (2015)

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
Dahkki: Shinkins, B, et al.
Almmustuhtton: (2017)

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
Dahkki: Shinkins, B, et al.
Almmustuhtton: (2017)

Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma.
Dahkki: Kim, J, et al.
Almmustuhtton: (1999)

Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer
Dahkki: Scurr, M, et al.
Almmustuhtton: (2015)

Surveillance for recurrence of colorectal cancer--reply.
Dahkki: Primrose, J, et al.
Almmustuhtton: (2014)

Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
Dahkki: Kim, J, et al.
Almmustuhtton: (2000)

A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.
Dahkki: Akamatsu, Y, et al.
Almmustuhtton: (1998)

Scheduled use of CEA and CT follow-up to detect recurrence of colorectal cancer: 6-12 year results from the FACS randomised controlled trial
Dahkki: Pugh, SA, et al.
Almmustuhtton: (2018)

Fabrication of graphene/gold-modified screen-printed electrode for detection of carcinoembryonic antigen
Dahkki: Chan, K. F., et al.
Almmustuhtton: (2016)

Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS randomized controlled trial
Dahkki: Pugh, SA, et al.
Almmustuhtton: (2016)

Relationship between nickel exposure and the level of carcinoembryonic antigen among welders in an automotive plant
Dahkki: Chiang, Lee Juan, et al.
Almmustuhtton: (2009)

Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
Dahkki: Conaghan, P, et al.
Almmustuhtton: (2008)

Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer.
Dahkki: Kim, J, et al.
Almmustuhtton: (2005)

Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.
Dahkki: Smithson, J, et al.
Almmustuhtton: (1996)

Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
Dahkki: Kim, J, et al.
Almmustuhtton: (2002)

Targeted killing of colorectal cell lines and murine adenomas using a monoclonal antibody against membrane bound carcinoembryonic antigen
Dahkki: Conaghan, P, et al.
Almmustuhtton: (2006)

A novel carcinoembryonic antigen t cell bispecific antibody (cea tcb) for the treatment of solid tumors
Dahkki: Bacac, M, et al.
Almmustuhtton: (2016)

Horseradish peroxidase-labeled silver/reduced graphene oxide thin film-modified screen-printed electrode for detection of carcinoembryonic antigen
Dahkki: Lee, S. X., et al.
Almmustuhtton: (2017)

The Role Of Fdg Pet-Ct In Detection Of Recurrent Colorectal Cancer In National Cancer Institute, Putrajaya, Malaysia
Dahkki: Wong, Teck Huat
Almmustuhtton: (2016)

Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
Dahkki: Primrose, J, et al.
Almmustuhtton: (2014)

What is the incidence of resectable recurrence after surgery for primary colorectal cancer? Evidence from the UK FACS (Follow-up After Colorectal Surgery) trial
Dahkki: Pugh, S, et al.
Almmustuhtton: (2012)

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Dahkki: Glaire, MA, et al.
Almmustuhtton: (2019)

Trends over time in the full blood count blood test for colorectal cancer detection
Dahkki: Virdee, PS, et al.
Almmustuhtton: (2020)

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
Dahkki: Stern, N, et al.
Almmustuhtton: (2005)

Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
Dahkki: Ilyas, M, et al.
Almmustuhtton: (1998)

Effect of 3-5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: FACS randomized controlled trial.
Dahkki: Mant, D, et al.
Almmustuhtton: (2013)

Korelasi Ekspresi Interleukin 6 Jaringan Kanker Kolorektal Dengan Kadar Carcinoembryonic Antigen Serum Penderita Adenokarsinoma Kolorektal
Dahkki: DAMAYANTI, RATNA
Almmustuhtton: (2015)

KORELASI EKSPRESI INTERLEUKIN 6 JARINGAN KANKER KOLOREKTAL DENGAN KADAR CARCINOEMBRYONIC ANTIGEN SERUM PENDERITA ADENOKARSINOMA KOLOREKTAL
Dahkki: , Ratna Damayanti, et al.
Almmustuhtton: (2013)

Prediction of colorectal cancer by consultation questionnaire.
Dahkki: Mant, D, et al.
Almmustuhtton: (2002)

Can safety netting improve cancer detection in patients with vague symptoms?
Dahkki: Nicholson, B, et al.
Almmustuhtton: (2016)

Can safety netting improve cancer detection in patients with vague symptoms?
Dahkki: Bankhead, C, et al.
Almmustuhtton: (2016)

Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): development of dynamic prediction models for early detection of colorectal cancer using trends in blood tests from primary care
Dahkki: Virdee, PS, et al.
Almmustuhtton: (2023)

Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis.
Dahkki: Ashraf, S, et al.
Almmustuhtton: (2009)

Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
Dahkki: Nolan, K, et al.
Almmustuhtton: (1999)

Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trial
Dahkki: Goh, V, et al.
Almmustuhtton: (2024)

CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules.
Dahkki: Watt, S, et al.
Almmustuhtton: (1991)

CEA monitoring in colorectal cancer is not a waste of time.
Dahkki: Mant, D, et al.
Almmustuhtton: (2014)